The buy now/pay later lender outperformed nearly every analyst estimate in its fiscal Q2 2025 earnings report. CEO Max Levchin said the company is 5 months out from positive GAAP operating income.
JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.
JMP Securities analyst Andrew Boone maintained a Buy rating on Snap (SNAP – Research Report) today and set a price target of $16.00. The ...
Hell hath no fury like an athletic prospect scorned. Nebraska football has learned this the hard way over the years, turning ...
Q3 2025 Earnings Conference Call February 6, 2025 8:30 AM ETCompany ParticipantsOlga Guyette - Vice President, ...
EssentiallySports on MSN7h
Penn State Suffers an Unexpected Setback to Non-Power Conference College as James Franklin Gets Taste of His Own MedicineAin’t no tale better than a karma tale. The post Penn State Suffers an Unexpected Setback to Non-Power Conference College as ...
Boyd Gaming Corporation ( NYSE: BYD) Q4 2024 Earnings Conference Call February 6, 2025 5:00 PM ET David Strow – Vice President-Corporate Communications Keith Smith – President and Chief Executive ...
Inc., the parent company of Google, stands at a critical juncture as it navigates a complex landscape of technological innovation, regulatory challenges, and market competition. With a market ...
Lets it fly in G League Dowtin wasn't afraid to take initiative on the offensive end during Sunday's clash, but he needed 24 attempts from the field to reach 21 points. This was an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback